(Q45858785)

17 December 2017

title

Nonviral genetic transfer of Fas ligand induced significant growth suppression and apoptotic tumor cell death in prostate cancer in vivo (English)

1 reference

17 December 2017

1 reference

Nakanishi H

1

1 reference

17 December 2017

Mazda O

2

1 reference

17 December 2017

Satoh E

3

1 reference

17 December 2017

Asada H

4

1 reference

17 December 2017

Morioka H

5

1 reference

17 December 2017

Kishida T

6

1 reference

17 December 2017

Nakao M

7

1 reference

17 December 2017

Mizutani Y

8

1 reference

17 December 2017

Kawauchi A

9

1 reference

17 December 2017

Kita M

10

1 reference

17 December 2017

Imanishi J

11

1 reference

17 December 2017

Miki T

12

1 reference

17 December 2017

publication date

1 March 2003

1 reference

17 December 2017

published in

Gene Therapy

1 reference

17 December 2017

volume

10

1 reference

17 December 2017

issue

5

1 reference

17 December 2017

page(s)

434-442

1 reference

17 December 2017

https://scigraph.springernature.com/pub.10.1038/sj.gt.3301912

exact match

0 references

cites work

Novel strategies and therapeutics for the treatment of prostate carcinoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Treatment of locally advanced prostate cancer: is chemotherapy the next step?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Efficient gene transduction by Epstein-Barr-virus-based vectors coupled with cationic liposome and HVJ-liposome

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Highly efficient suicide gene expression in hepatocellular carcinoma cells by epstein-barr virus-based plasmid vectors combined with polyamidoamine dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Effective suicide gene therapy in vivo by EBV-based plasmid vector coupled with polyamidoamine dendrimer

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Targeted killing of carcinoembryonic antigen (CEA)-producing cholangiocarcinoma cells by polyamidoamine dendrimer-mediated transfer of an Epstein-Barr virus (EBV)-based plasmid vector carrying the CEA promoter

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Polyethylenimine-mediated suicide gene transfer induces a therapeutic effect for hepatocellular carcinoma in vivo by using an Epstein-Barr virus-based plasmid vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Extremely efficient gene transfection into lympho-hematopoietic cell lines by Epstein-Barr virus-based vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

In vivo electroporation-mediated transfer of interleukin-12 and interleukin-18 genes induces significant antitumor effects against melanoma in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

In vivo gene gun-mediated transduction into rat heart with Epstein-Barr virus-based episomal vectors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Direct intra-cardiomuscular transfer of beta2-adrenergic receptor gene augments cardiac output in cardiomyopathic hamsters

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Highly efficient gene transfer into murine liver achieved by intravenous administration of naked Epstein-Barr virus (EBV)-based plasmid vectors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Non-viral vectors in cancer gene therapy: principles and progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Development of biomaterials for gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Characterization of Fas (Apo-1, CD95)-Fas ligand interaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Adenovirus-mediated expression of Fas ligand induces apoptosis of human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Fas-mediated apoptosis in seven human prostate cancer cell lines: correlation with tumor stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Phosphoinositide-specific inositol polyphosphate 5-phosphatase IV inhibits Akt/protein kinase B phosphorylation and leads to apoptotic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Gene expression profile of antithrombotic protein c defines new mechanisms modulating inflammation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Suicide gene therapy on LNCaP human prostate cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

The influence of polymer structure on the interactions of cationic polymers with DNA and morphology of the resulting complexes

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Metalloproteinase-mediated release of human Fas ligand

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Conversion of membrane-bound Fas(CD95) ligand to its soluble form is associated with downregulation of its proapoptotic activity and loss of liver toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Downregulation of Fas ligand by shedding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Restricted expression of an adenoviral vector encoding Fas ligand (CD95L) enhances safety for cancer gene therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

A complex adenovirus vector that delivers FASL-GFP with combined prostate-specific and tetracycline-regulated expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Gene transfer of Fas ligand induces tumor regression in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Antitumor effect of allogenic fibroblasts engineered to express Fas ligand (FasL).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Interleukin 2 gene therapy for prostate cancer: phase I clinical trial and basic biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Phase I/II trial evaluating combined radiotherapy and in situ gene therapy with or without hormonal therapy in the treatment of prostate cancer--a preliminary report

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Stable replication of plasmids derived from Epstein-Barr virus in various mammalian cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Efficient selection for high-expression transfectants with a novel eukaryotic vector

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Increased cytotoxicity of cadmium in fibroblasts lacking c-fos

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

In vivo delivery to tumors of DNA complexed with linear polyethylenimine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

Significant Antitumor Effects Obtained by Autologous Tumor Cell Vaccine Engineered to Secrete Interleukin (IL)-12 and IL-18 by Means of the EBV/Lipoplex

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

7 January 2021

Successful transfer of ADA gene in vitro into human peripheral blood CD34+ cells by transfecting EBV-based episomal vectors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

7 January 2021

Modulation of growth and apoptosis response in PC-3 and LNCAP prostate-cancer cell lines by Fas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

7 January 2021

Delivery of antisense oligonucleotides and plasmid DNA with various carrier agents

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

7 January 2021

Controlled Fas ligand gene expression by Cre/loxP-mediated switching system: high levels of FasL expression result in lethal hepatitis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

7 January 2021

Fas ligand in human serum

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

7 January 2021

Immunosensitization of prostate carcinoma cell lines for lymphocytes (CTL, TIL, LAK)-mediated apoptosis via the Fas-Fas-ligand pathway of cytotoxicity

1 reference

https://api.crossref.org/works/10.1038%2FSJ.GT.3301912

7 January 2021

Identifiers

DOI

10.1038/SJ.GT.3301912

1 reference

17 December 2017

Dimensions Publication ID

0 references

1 reference

17 December 2017